Rhythm Pharmaceuticals (RYTM) Non-Current Assets (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Non-Current Assets of $12.2 million for Q1 2026, down 29.72% year-over-year from $17.4 million in Q1 2025, and down 7.94% quarter-over-quarter from $13.3 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Non-Current Assets (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Non-Current Assets for 11 consecutive years, with $12.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 29.72% year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at $49.6 million (down 40.33% YoY), while the FY2025 annual figure was $13.3 million, down 26.52% from the prior year.
- Non-Current Assets declined to $12.2 million in Q1 2026 per RYTM's latest filing, from $13.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $31.4 million in Q1 2022 and bottomed at $12.1 million in Q2 2025.
- Historically, Non-Current Assets has averaged $22.0 million across 5 years, with a median of $24.5 million in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 211.41% — and 2025, when it sank 50.76%.
- Rhythm Pharmaceuticals' Non-Current Assets stood at $28.2 million in 2022, then fell by 13.34% to $24.5 million in 2023, then dropped by 26.16% to $18.1 million in 2024, then slipped by 26.52% to $13.3 million in 2025, then slipped by 7.94% to $12.2 million in 2026.
- Business Quant data shows RYTM's Non-Current Assets at $12.2 million in Q1 2026, $13.3 million in Q4 2025, and $12.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 10.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.70 Mn |
| Mar 31, 2026 | 12.23 Mn |
| Dec 31, 2025 | 13.28 Mn |
| Sep 30, 2025 | 12.07 Mn |
| Jun 30, 2025 | 12.05 Mn |
| Mar 31, 2025 | 17.40 Mn |
| Dec 31, 2024 | 18.07 Mn |
| Sep 30, 2024 | 23.23 Mn |
| Jun 30, 2024 | 24.48 Mn |
| Mar 31, 2024 | 22.90 Mn |
| Dec 31, 2023 | 24.48 Mn |
| Sep 30, 2023 | 25.00 Mn |
| Jun 30, 2023 | 26.07 Mn |
| Mar 31, 2023 | 27.84 Mn |
| Dec 31, 2022 | 28.25 Mn |
| Sep 30, 2022 | 27.74 Mn |
| Jun 30, 2022 | 28.34 Mn |
| Mar 31, 2022 | 31.38 Mn |
| Dec 31, 2021 | 21.14 Mn |
| Sep 30, 2021 | 20.19 Mn |